Aurinia Pharmaceuticals Inc. (AUPH) Stock Quotes

Official company branding of auriniapharma.com (AUPH)

Aurinia Pharmaceuticals (AUPH) develops unique targeted therapies to combat severe forms of lupus, preventing renal failure. The business relies on the expansion of Lupkynis, which guarantees excellent free cash flow and high profitability, with the key metric standing at 15.50. The current stock quotes visualized below confirm the resilience of the company, which is protected by patents for an exclusive oral therapy method for rare autoimmune pathologies.

Quote Chart: Aurinia Corp (AUPH) for 07/04/2022 - 11/17/2026

Aurinia Pharma - analytical breakdowns and key metrics (AUPH)

Fundamental valuation:auriniapharma.com
Signature product of Aurinia Pharmaceuticals Inc

The price captures the current market value of the business stake, reflecting the aggregate assessment of risks and shareholder expectations. Price action measures the market's confidence in the company's ability to generate cash flow. By analyzing the financial asset's rate, an investor determines the entry point during fundamental undervaluation. For Aurinia Pharmaceuticals (AUPH), volatility depends directly on the sales volumes of its kidney therapy drug. Chart pullbacks signal a revision of sales forecasts for the prescription medication.

Analysis of competing companies

Stock Price ARGX|Price Chart BNTX (BioNTech Inc.)|Stock Price ABVX (Abivax S.A.)|ADMA: Share Price|Protagonist Corp - Stock Price|IMVT: Price Chart|KNSA: Stock Price|GRFS - Market Chart|Price Chart Adaptive Biotechnologies Corporation|Celldex - Quote Chart|Stock Price BCRX|VERA (Vera Therapeutics, Inc.) - Price Performance Chart|Stock Price DNTH (dianthustx.com)|Stock Price Pharvaris NV PHVS|ABCL - Price Chart|Price Performance Chart TRML (Tourmaline)|precigen.com (PGEN) - Price Chart|Stock Quotes Pharming Group N.V.|NKTR (nektar.com) - Stock Price|UPB: Price Performance Chart|Stock Quotes ZBIO (Zenas Biopharma, Inc.)|IMNM (Immunome Corp) - Price Performance Chart|Stock Price GOSS (gossamerbio.com)|Market Chart kalvista.com (KALV)|SEPN - Price Chart|Pieris Pharma (PVLA) - Stock Quotes|Savara Pharma (SVRA) - Price Chart|Stock Quotes Rigel Pharmaceuticals|Stock Quotes ANAB|Stock Price astriatx.com|Price Chart enGene Bio (ENGN)|RAPT Therapeutics, Inc. - Share Price|Stock Price JBIO (Aerovate Therapeutics)|Aclaris (ACRS) - Market Price|KYTX - Price Chart|Tiziana Life Sciences - Price|CABA: Stock Price|Market Price Ventyx Biosciences Inc. (VTYX)|THTX (theratech.com) - Stock Price|Stock Price Avalo Therapeutics Inc|Stock Price ELDN|Agenus Inc. - Share Price|Stock Price CLYM (Climb Bio)|Price Performance Chart ZURA|ATYR - Price Chart|ADAG (adagene.com) - Share Price|IMA: Stock Price|Stock Quotes Shattuck Therapeutics|Stock Quotes EQ|CNTB: Price Performance Chart|Stock Price IMUX|ATRA - Market Price|inflarx.de - Stock Quotes|Stock Price X4 Pharma XFOR|Adicet Bio - Stock Price|Price Performance Chart CELU (celularity.com)|INMB: Stock Price|BRNS - Market Chart|KZR (kezarlifesciences.com) - Stock Price|SAB Biotherapeutics - Quote Chart|Stock Quotes AKTX (akaritx.com)|ENLV: Quote Chart|Stock Price QTTB (Q32 Bio Corp)|GOVX - Stock Quotes|EDSA - Price Chart|IBIO - Stock Price|CARM (carismatx.com) - Stock Quotes|XTLB: Price|BOLT (Bolt Biotherapeutics, Inc.) - Stock Price|HCW Biologics Inc. (HCWB) - Market Chart|Price Chart Aptevo (APVO)|Stock Price aimimmuno.com (AIM)|Price Chart Aditxt ADTX|Stock Price GRI Bio Corp GRI|XRTX - Price Chart|HIND (ReShape Lifesciences) - Share Price|revbiosciences.com (REVB) - Price Chart|INDP - Market Chart|SCNI (Scinai Immunotherapeutics Ltd) - Stock Price|Stock Price calcimedica.com|Stock Price AFMD|Market Chart Allakos Inc|Stock Price HOOK (HOOKIPA Pharma Inc.)|IGMS (IGM Bio) - Quote Chart|ITOS - Price Chart|Quote Chart OCEA|TC Biopharm (TCBP) - Price Chart|Stock Quotes Third Harmonic Bio, Inc